What does the research say about Modified 5-factor Frailty Index?

Modified 5-factor Frailty Index

There are 6 papers on modified 5-factor Frailty Index in aging research: 6 observational studies in people.

6 papers study it12 more mention it6 findings

“mFI-5 (C-statistic 0.677 [95% CI 0.675-0.679], p < 0.0001, DeLong test)”

Mortality

upin humans2

2 studies

Modified 5-factor Frailty Index predicts mortality in humans (emergent and elective inguinal or femoral hernia repairs) (AUC 0.86 emergent, 0.80 elective).
“Area under the curve was calculated for emergent and elective groups, including mortality (0.86, 0.80)”
Humansemergent and elective inguinal or femoral hernia repairsn = 41,897
Assessing the mFI-5 frailty score and functional status in geriatric patients undergoing inguinal hernia repairs
Hernia : the journal of hernias and abdominal wall surgeryOct 25, 2023
Modified 5-factor Frailty Index predicts mortality in humans (C-statistic 0.677 [95% CI 0.675-0.679], p < 0.0001).
“mFI-5 (C-statistic 0.677 [95% CI 0.675-0.679], p < 0.0001, DeLong test)”
Humansn = 292,225
Comparison of the Risk Analysis Index and the modified 5-factor frailty index in predicting 30-day morbidity and mortality after spine surgery
Journal of neurosurgery. SpineApr 7, 2023

Modified 11-factor Frailty Index

upin humans1

1 study

Modified 5-factor Frailty Index is associated with modified 11-factor Frailty Index in humans (ovarian cancer undergoing cytoreductive surgery with HIPEC) (spearman rho 0.98, p < 0.001).
“mFI5 and mFI11 scores for frailty were highly correlated (spearman rho 0.98, p < 0.001).”
Humansovarian cancer undergoing cytoreductive surgery with HIPECfemalesn = 141
The modified 5-factor frailty index predicts postoperative outcomes in patients with ovarian cancer undergoing hyperthermic intraperitoneal chemotherapy
Surgical oncologyOct 3, 2024

Discharge to facility or home services

upin humans1

1 study

Modified 5-factor Frailty Index predicts discharge to facility or home services in humans (ovarian cancer undergoing cytoreductive surgery with HIPEC) (22.7 % vs. 6.8 %, 18.2 % vs 8.5 %, p = 0.025).
“Frail patients were more likely to be discharged to a skilled nursing facility (22.7 %) vs. 6.8 % of non-frail patients, or require home services (18.2 % vs 8.5 %, p = 0.025).”
Humansovarian cancer undergoing cytoreductive surgery with HIPECfemalesn = 141
The modified 5-factor frailty index predicts postoperative outcomes in patients with ovarian cancer undergoing hyperthermic intraperitoneal chemotherapy
Surgical oncologyOct 3, 2024

Postoperative complications

upin humans1OR 3.08

1 study

Modified 5-factor Frailty Index predicts postoperative complications in humans (ovarian cancer undergoing cytoreductive surgery with HIPEC) (OR 3.08, p = 0.024).
“On multivariable logistic regression, frail patients were more likely to experience moderate or higher Accordion postoperative complications (OR 3.08, p = 0.024).”
Humansovarian cancer undergoing cytoreductive surgery with HIPECfemalesn = 141
The modified 5-factor frailty index predicts postoperative outcomes in patients with ovarian cancer undergoing hyperthermic intraperitoneal chemotherapy
Surgical oncologyOct 3, 2024

Pneumonia

upin humans1

1 study

Modified 5-factor Frailty Index predicts pneumonia in humans (emergent and elective inguinal or femoral hernia repairs) (AUC 0.82 emergent, 0.77 elective).
“pneumonia (0.82, 0.77), discharge destination not home (0.78, 0.73), prolonged LOS (0.69, 0.66), and infection (0.71, 0.62).”
Humansemergent and elective inguinal or femoral hernia repairsn = 41,897
Assessing the mFI-5 frailty score and functional status in geriatric patients undergoing inguinal hernia repairs
Hernia : the journal of hernias and abdominal wall surgeryOct 25, 2023